49Care, a women’s health innovation company, has launched SELF Menopause, the first at-home menopause test kit approved by Health Canada. The product is now available in pharmacies across Canada, offering women a private and convenient way to track their menopause journey from their homes.
SELF Menopause targets women experiencing symptoms that may indicate perimenopause or menopause, including unusual tiredness, irregular periods, anxiety, or overwhelming stress. The kit contains three urine tests that measure follicle-stimulating hormone (FSH), a key indicator of menopause status, with an accuracy rate of over 99%.
“Women deserve clarity and control over their health, especially during the menopause transition,” said Marion Ulmann, Executive Director of 49Care. “With SELF Menopause, we are removing barriers to information and empowering women to take charge of their well-being with confidence and privacy.”
The test is designed to help women determine if they are in the very early stage of perimenopause, entering early menopause, or in menopause itself. Unlike traditional testing methods, SELF Menopause does not require blood samples, doctor’s appointments, or app downloads. The process can be completed at home in minutes, offering a simple and private solution.
